CONALT PHARMACEUTICAL INDUSTRY TRD LTD
Registered number: 13311957
Balance Sheet
as at 30 April 2024
2024
£
Current assets
Cash at bank and in hand 100
100
Capital and reserves
Called up share capital 100
Profit and loss account -
Shareholders' funds 100
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 480 of the Companies Act 2006 relating to dormant companies.
Members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. A profit and loss account has not been delivered to the Registrar of Companies.
Davron ISHMURODOV, Asim KAZIMOV
Director
Approved by the board on 20 November 2024
CONALT PHARMACEUTICAL INDUSTRY TRD LTD
Notes to the Accounts
for the year ended 30 April 2024
1 Accounting policies
The accounts have been prepared under the historical cost convention.
2 Controlling party
3 Other information
CONALT PHARMACEUTICAL INDUSTRY TRD LTD is a private company limited by shares and incorporated in England. Its registered office is:
17 Green Lanes
LONDON
N16 9BS
CONALT PHARMACEUTICAL INDUSTRY TRD LTD 13311957 true 2023-05-01 2024-04-30 2024-04-30 VT Final Accounts April 2024 Davron ISHMURODOV, Asim KAZIMOV No description of principal activity 13311957 2023-05-01 2024-04-30 13311957 bus:EntityNoLongerTradingButTradedInPast 2023-05-01 2024-04-30 13311957 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 13311957 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 13311957 bus:Director40 2023-05-01 2024-04-30 13311957 countries:England 2023-05-01 2024-04-30 13311957 bus:FRS102 2023-05-01 2024-04-30 13311957 bus:FilletedAccounts 2023-05-01 2024-04-30 13311957 2024-04-30 13311957 core:ShareCapital 2024-04-30 13311957 core:RetainedEarningsAccumulatedLosses 2024-04-30 13311957 2023-04-30 iso4217:GBP